Last reviewed · How we verify
NCT05627531
Meaning Making While Your Child is in Intensive Care
NA trial testing Narrative Medicine in Narrative Medicine in 41 participants. Completed in 9 September 2024.
9 September 2024
Quick facts
| Lead sponsor | Akron Children's Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 41 |
| Start date | 9 November 2022 |
| Primary completion | 9 September 2024 |
| Estimated completion | 9 September 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Narrative Medicine
Conditions studied
- Narrative Medicine — all drugs for Narrative Medicine →
Sponsor
Akron Children's Hospital
Who can join
18 and older, any sex, with Narrative Medicine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A quarter of a million children and teenagers are hospitalized annually in Pediatric Intensive Care Units (PICUs) in North America. Having a child hospitalized in a PICU is stressful and affects the mood and coping of their parents. The investigators' prior work has shown how narrative medicine may help. Narrative medicine includes at least one session reading and then having a guided discussion of a poem or short story. The readings are individually selected by the Narrative Medicine Coordinator who also provides a guided writing exercise (in the form of poetry, creative non-fiction, journaling, or fiction). After writing, the parent/guardian had the option to share their writing out loud with the Narrative Medicine Coordinator. At the end of each session, the parent/guardian receives personalized writing prompts they are encouraged to use writing each day. The Investigators want to see how this session helps parents make sense of their time in the PICU and how it may help them cope. The investigators ask participants to fill out some surveys when they enroll and three days after their session.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05627531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Narrative Medicine
Currently open trials in the same condition.
- NCT06310109 — Effect of Pediatric Intensive Care Unit Diaries on PICS-p · NA · recruiting
Other Akron Children's Hospital trials
Trials by the same sponsor.
- NCT07221630 — Conventional Ultrafiltration Versus Dilutional Ultrafiltration in Pediatric CPB Patients · not yet recruiting
- NCT06226610 — Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic · Phase 2 · recruiting
- NCT03053401 — Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05627531 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Akron Children's Hospital
- Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05627531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing